AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Salus Scientific closes an oversubscribed Series A financing, raising $10.1 million to fund commercial scale-up and expand production capacity.
Amount Raised
$10.1 Million
Round Type
Series A
CharlestonBiotechnologyDescription
Salus Scientific today announced the successful closing of its oversubscribed Series A financing, raising a total of $10.1 million. The round closed above the initial target of $8.0 million due to strong investor demand. The new capital will support the company's growth and infrastructure development. CEO Todd Flohr expressed excitement about the investor commitment and its alignment with the company's vision.
Fundz sees it the moment Salus Scientific raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
Based on industry dataSalus Scientific raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.